Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.06.03.494776

Proteomic Dynamics of Breast Cancers Identifies Potential Therapeutic Protein Targets

Abstract

Treatment and relevant targets for breast cancer (BC) remain limited, especially for triple-negative BC (TNBC). We quantified the proteomes of 76 human BC cell lines using data independent acquisition (DIA) based proteomics, identifying 6091 proteins. We then established a 24-protein panel distinguishing TNBC from other BC types. Integrating prior multi-omics datasets with the present proteomic results to predict the sensitivity of 90 drugs, we found that proteomics data improved drug sensitivity predictions. The sensitivity of the 90 drugs was mainly associated with cell cytoskeleton, signal transduction and mitochondrial function. We next profiled the proteome changes of nine cell lines (five TNBC cell lines, four non-TNBC cell lines) perturbated by EGFR/AKT/mTOR inhibitors. In the TNBC cell lines, metabolism pathways were dysregulated after EGFR/mTOR inhibitors treatment, while RNA modification and cell cycle pathways were dysregulated after AKT inhibitor treatment. Our study presents a systematic multi-omics and in-depth analysis of the proteome of BC cells. This work aims to aid in prioritization of potential therapeutic targets for TNBC as well as to provide insight into adaptive drug resistance in TNBC.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sun, R., Zhu, Y. J., Savad, A., Ge, W., Luna, A., Liang, S., Segura, L. T., Rajapakse, V. N., Yu, C., Zhang, H., Fang, J., Wu, F., Xie, H., Saez-Rodriguez, J., Ying, H., Reinhold, W. C., Sander, C., Pommier, Y., Neel, B. G., Guo, T., Aebersold, R.. 2022-06-05. Proteomic Dynamics of Breast Cancers Identifies Potential Therapeutic Protein Targets. https://doi.org/10.1101/2022.06.03.494776

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Large language models complement established workflows for mechanistic model construction and refinement in systems biology

Mechanistic models provide a framework for describing, understanding, and predicting biological processes, but their development requires an interdisciplinary team with expertise in biology, mathematics, and computation. Here we present Octomod, a multi-agent workflow based on large language models (LLMs) that integrates biological knowledge retrieval, model construction, parameter estimation, and hypothesis testing. Built on established software tools, including AMICI and pyPESTO, and community standards, including SBML and PEtab, Octomod supports model development and refinement through natural-language interaction with a user. The agents' proposals must pass defined checks and the user's decision before they are used. Every input, model, check, and decision is recorded, so that model building remains transparent and reproducible. We applied Octomod to four problems. Three used published data and differ in model size and in how much the user guided the run: Octomod constructed a model that matched a published model without user guidance, supported the interactive refinement of a gene-regulatory model, and built models of cell-cell communication that explained the responses of five immune cell types to different stimuli. In the fourth application, on newly generated and unpublished lipidomics data, Octomod helped to determine which processes the measurements could inform, identify unresolved label fluxes, and reduce a supplied model to those processes. Together, these results show how LLMs can strengthen and complement established workflows for constructing and refining biologically informed models.

systems biology↗

Dynamic rewiring of super-enhancers shapes condition-specific genome regulation

Enhancers and promoters communicate through three-dimensional chromatin contacts to control cell13 type-specific gene expression. While chromosome conformation capture has enabled genome-wide mapping of these contacts, and graph-based analyses of the resulting interaction networks have shown that super enhancers occupy highly connected positions. However, how the network positions of super enhancers and typical enhancers changes as cells transition between states remains unclear. In this study, enhancer-promoter networks from high-resolution Hi-C data were constructed, and network18 based approaches were applied to characterize the regulatory architecture and its remodeling during differentiation, using Hi-C and HiChIP datasets from three differentiation systems: PMA-induced K562 differentiation, cardiomyocyte differentiation of h9 cells, and differentiation of primary foreskin keratinocytes. The networks are modular, with the largest clusters consisting of promoters and both enhancer types. Super-enhancer constituents and typical enhancers occupy distinct topological positions. During differentiation, network structure is mainly reshaped by enhancer turnover rather than by enhancer reorganization. Among the persistent enhancers, super-enhancer constituents rewire more extensively than typical enhancers. Functionally, remodeled super-enhancers connect to promoters controlling cell type's identity-defining programs, whereas typical enhancers connect to promoters involved in general metabolic and stress-response loci. These results provide evidence that super-enhancers act as a sensitive, identity-focused layer of chromatin communication. The present study also providesquantitative, network-level evidence for how super-enhancers shape the architecture of chromatin communication.

systems biology↗

A Mathematical Model Connecting Appetite-Driven Food Intake to Metabolic Changes across Diet and GLP-1RA Treatments in Mice

Mouse models are widely used to study obesity and the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on appetite-driven meal responses and eating behaviours. However, connecting these behavioural changes to disease prevention remains limited. One reason is that eating behaviour is often summarised as daily or weekly energy intake, obscuring meal-level dynamics. Here we present a mathematical model of mouse appetite-driven food intake across diets and treatment with the GLP-1RAs semaglutide and exenatide. The model jointly described three studies and passed both qualitative assessments and a statistical {chi}2 test (disagreement<threshold, 348<1111). Predictive performance was subsequently validated using four pre-existing studies and one new study. Finally, the model was used to simulate mouse populations under dietary and GLP-1RA interventions, with predictions showing qualitative agreement with the literature. This work aids preclinical drug discovery, supports mouse study design, and improves understanding of how individual meals accumulate into long-term physiological changes.

systems biology↗